4/A//SEC Filing
Finigan Paul M 4/A
Accession 0001030653-09-000030
CIK 0001030653other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:15 PM ET
Size
5.2 KB
Accession
0001030653-09-000030
Insider Transaction Report
Form 4/AAmended
CURAGEN CORPCRGN
Finigan Paul M
Former EVP & General Counsel
Transactions
- Disposition to Issuer
Common Stock
2009-10-01−75,000→ 0 total
Footnotes (1)
- [F1]Footnote (1) of the original Form 4 is amended and restated in its entirety to read as follows: "Disposed of pursuant to merger agreement between issuer and Celldex Therapeutics, Inc. in exchange for 20,542 shares of Celldex Therapeutics, Inc. common stock."
Documents
Issuer
CURAGEN CORP
CIK 0001030653
Entity typeother
Related Parties
1- filerCIK 0001370953
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 5:15 PM ET
- Size
- 5.2 KB